Publikasi Scopus Covid-19 Per 15 Juni 2023 (346 artikel)

author_full_names

Depfenhart, Markus (15062353700); de Villiers, Danielle (57216933867); Lemperle, Gottfried (57216795009); Meyer, Markus (57217373886); Di Somma, Salvatore (7003878465)

authors

Depfenhart M.; de Villiers D.; Lemperle G.; Meyer M.; Di Somma S.

title

Potential new treatment strategies for COVID-19: is there a role for bromhexine as add-on therapy?

source_title

Internal and Emergency Medicine

abstract

Of huge importance now is to provide a fast, cost-effective, safe, and immediately available pharmaceutical solution to curb the rapid global spread of SARS-CoV-2. Recent publications on SARS-CoV-2 have brought attention to the possible benefit of chloroq

author_keywords

Bromhexine; COVID-19; Prophylactic; Protease inhibitor; SARS-CoV-2; Treatment

funding_texts

correspondence_address

M. Depfenhart; Faculty of Medicine, Venlo University B.V, Venlo, Netherlands; email: This email address is being protected from spambots. You need JavaScript enabled to view it.

publisher

Springer

issn

18280447

pubmed_id

32458206

abbreviated_source_title

Intern. Emerg. Med.

authors_with_affiliations

Depfenhart M., Faculty of Medicine, Venlo University B.V, Venlo, Netherlands, Medical One Clinic Hamburg, Hamburg, Germany; de Villiers D., Research and Development, Medika SA, Pretoria, South Africa; Lemperle G., Division of Plastic Surgery, University o

affiliations

Faculty of Medicine, Venlo University B.V, Venlo, Netherlands; Medical One Clinic Hamburg, Hamburg, Germany; Research and Development, Medika SA, Pretoria, South Africa; Division of Plastic Surgery, University of California, San Diego, United States; Facu

author_s_id

15062353700; 57216933867; 57216795009; 57217373886; 7003878465

cited_by

year

2020

link

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85085389082&doi=10.1007%2fs11739-020-02383-3&partnerID=40&md5=af7f1a7229b9ae08a938f3ac43a234ee

document_type

Review